ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8,201 | 84.62695 | 1 | female | 0 | 13 | 582 | CHF | COPD/CHF/Cirrhosis | 4 | 13 | null | 0 | 7,392 | 6,289.4883 | 5,005.32812 | 11.5 | white | 15.798828 | 31 | 0.849976 | 0.75293 | 1 | 1 | 0 | no | null | null | no dnr | 13 | 71 | 11.398438 | 70 | 24 | 36.79688 | null | 3.899902 | 0.199982 | 1.799805 | 134 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
8,202 | 88.17499 | 1 | male | 0 | 8 | 385 | CHF | COPD/CHF/Cirrhosis | 3 | 6 | under $11k | 0 | 5,614 | 4,470.8594 | 3,149.31836 | 13.5 | white | 15.599609 | 45 | 0.840942 | 0.738892 | 1 | 1 | 0 | no | 0.75 | 0.7 | no dnr | 8 | 76 | 7.599609 | 64 | 28 | 35.79688 | 237.5 | 4.299805 | 0.399963 | 1.799805 | 137 | 7.449219 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
8,203 | 74.125 | 1 | male | 0 | 5 | 1,237 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 37,841 | 27,540.0938 | 24,555.875 | 19 | white | 21.097656 | 17 | 0.73291 | 0.580933 | 24 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 5 | 77 | 8.898438 | 60 | 24 | 36.29688 | 404 | 2.599609 | 0.5 | 0.899902 | 139 | 7.279297 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,204 | 60.20798 | 1 | female | 0 | 5 | 147 | Lung Cancer | Cancer | 3 | null | null | 0 | 2,978 | 1,929.8897 | 2,192.82812 | 11 | white | 11.699219 | 19 | 0.806885 | 0.588989 | 1 | 0 | 0 | metastatic | 0.3 | 0.1 | no dnr | 5 | 102 | 1.399902 | 114 | 20 | 36.89844 | 354.25 | 4.199219 | 0.5 | 0.599976 | 137 | 7.489258 | null | null | null | null | null | null | 2.162598 |
8,205 | 78.49396 | 1 | male | 0 | 5 | 19 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 2,454 | 1,688.2568 | 1,355.39941 | 11 | white | 18.796875 | 23 | 0.832886 | 0.727905 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 5 | 71 | 12.798828 | 66 | 24 | 36.19531 | null | null | null | 1.599854 | 140 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
8,206 | 74.146 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 26 | 19,965 | 15,764.0625 | 14,631.1797 | 27 | white | 36.398438 | 45 | 0.274963 | 0.166992 | 1 | 0 | 0 | yes | 0.15 | 0.1 | dnr after sadm | 2 | 106 | 24.898438 | 114 | 10 | 35.29688 | 147.5 | 3.099609 | 0.599976 | 3.399902 | 132 | 7.449219 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
8,207 | 69.40198 | 1 | male | 0 | 56 | 116 | COPD | COPD/CHF/Cirrhosis | 5 | 12 | $25-$50k | 0 | 75,868 | 49,369.375 | 48,814.5312 | 22.5 | white | 30.398438 | 56 | 0.674927 | 0.503906 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 56 | 73 | 9.099609 | 60 | 10 | 35.5 | 153.84375 | null | 4.099609 | 2.599609 | 143 | 7.279297 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
8,208 | 78.78998 | 0 | male | 0 | 39 | 1,552 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 44 | 87,229 | 58,370.875 | 53,972 | 36 | white | 31.199219 | 52 | 0.314941 | 0.201996 | 5 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 39 | 68 | 21 | 40 | 12 | 38.19531 | 163.0625 | 3.199707 | 2 | 3.899902 | 135 | 7.319336 | null | null | null | null | 1 | null | 1 |
8,209 | 76.71198 | 1 | male | 0 | 16 | 669 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 9 | 30,223 | 22,569.3125 | 17,698.5469 | 17.333328 | white | 28.898438 | 65 | 0.553955 | 0.441956 | 8 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 16 | 59 | 16.796875 | 72 | 32 | 35.89844 | 126.51562 | null | null | 11.599609 | 145 | 7.419922 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,210 | 75.849 | 1 | male | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 133,616 | 93,028.6875 | 77,854.625 | 53.666657 | white | 30.796875 | 60 | 0.535889 | 0.421997 | 13 | 0 | 0 | no | null | null | dnr after sadm | 18 | 56 | 21.898438 | 112 | 24 | 39.19531 | 189 | null | null | 5.699219 | 138 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 2.270508 |
8,211 | 70.35199 | 1 | female | 0 | 19 | 1,360 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 30,342 | 19,691.1719 | 17,380.3281 | 23 | white | 13.798828 | 35 | 0.903931 | 0.837891 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 19 | 79 | 9.798828 | 69 | 26 | 35.89844 | null | 4.199219 | 0.199982 | 1.199951 | 134 | null | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
8,212 | 50.23999 | 1 | female | 0 | 28 | 38 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 138,255 | 92,819.25 | 102,443.938 | 38.25 | white | 28.097656 | 30 | 0.716919 | 0.630981 | 62 | 0 | 0 | no | null | null | dnr after sadm | 27 | 119 | 2 | 108 | 34 | 39.39844 | 187.5 | null | null | 1.099854 | 143 | 7.489258 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,213 | 67.38898 | 1 | male | 0 | 17 | 27 | MOSF w/Malig | ARF/MOSF | 4 | 8 | under $11k | 61 | 51,502 | 36,644.375 | 31,339.8281 | 17 | white | 21.699219 | 45 | 0.280945 | 0.171997 | 15 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 107 | 15 | 36 | 30 | 38.09375 | 214.28125 | null | null | 1 | 133 | 7.489258 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
8,214 | 68.92297 | 0 | male | 0 | 4 | 1,549 | CHF | COPD/CHF/Cirrhosis | 3 | 13 | under $11k | 0 | 2,206 | 1,526.5645 | 1,304.58984 | 3 | white | 18.898438 | 34 | 0.861938 | 0.770996 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 111 | 6.399414 | 42 | 29 | 36.59375 | 271.375 | 3.899902 | 1.199951 | 1.5 | 137 | 7.459961 | null | null | null | null | null | no(M2 and SIP pres) | 2.032715 |
8,215 | 71.50995 | 0 | male | 0 | 11 | 1,547 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 20,986 | 13,111.0078 | 11,977.3672 | 22.5 | white | 15.5 | 28 | 0.886963 | 0.81189 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 68 | 7.5 | 65 | 20 | 36.19531 | 493.3125 | 3.799805 | 0.5 | 1.599854 | 136 | 7.549805 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
8,216 | 75.22198 | 1 | female | 0 | 25 | 724 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 44,402 | 28,899.2344 | 27,155.0156 | 35.5 | white | 17 | 22 | 0.862915 | 0.814941 | 1 | 0 | 0 | no | null | null | no dnr | 25 | 64 | 11.099609 | 75 | 10 | 38 | 186.65625 | 3.199707 | 0.5 | 1 | 134 | 7.509766 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,217 | 79.36499 | 1 | female | 0 | 33 | 715 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | under $11k | 0 | 83,102 | 63,425.4688 | 50,705.875 | 18 | white | 20.796875 | 27 | 0.736938 | 0.654907 | 19 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 33 | 70 | 23 | 72 | 28 | 36.29688 | 360 | null | null | 1.699951 | 141 | 7.449219 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
8,218 | 49.80399 | 1 | male | 0 | 3 | 84 | Lung Cancer | Cancer | 2 | 17 | $25-$50k | 0 | 2,533 | 1,633.0664 | 1,550.70996 | 13 | white | 12.798828 | 13 | 0.80896 | 0.590942 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 103 | 6.399414 | 79 | 20 | 36.39844 | null | 3.599609 | 0.299988 | 1 | 135 | null | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.041992 |
8,219 | 53.39398 | 1 | female | 0 | 5 | 325 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 3,540 | 2,517.4844 | 2,616.35938 | 9 | white | 8.099609 | 11 | 0.860962 | 0.688965 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 93 | 5.899414 | 98 | 20 | 36.39844 | null | 4.399414 | 0.299988 | 0.699951 | 133 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.732666 |
8,220 | 65.79297 | 1 | male | 0 | 3 | 161 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 3,527 | 1,990.7373 | 1,217.95996 | 13 | white | 11.099609 | 11 | 0.805908 | 0.586914 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 93 | 15.5 | 76 | 20 | 36.59375 | null | 3.899902 | 0.699951 | 1.199951 | 136 | null | null | null | null | null | null | null | 1.825928 |
8,221 | 90.79297 | 1 | female | 1 | 6 | 6 | Coma | Coma | 2 | null | null | 61 | 5,507 | 3,241.8184 | 2,811.71875 | 30 | white | 21.296875 | 48 | 0.145996 | 0.094986 | 1 | 1 | 0 | yes | 0.05 | 0.000125 | dnr after sadm | 1 | 55 | 7.599609 | 45 | 32 | 37.89844 | 319 | null | null | 1.299805 | 139 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 3.229004 |
8,222 | 78.25098 | 1 | male | 0 | 11 | 109 | Lung Cancer | Cancer | 1 | 16 | $11-$25k | 0 | 11,474 | 7,410.6758 | 6,662.26953 | 7.5 | white | 11.298828 | 22 | 0.780884 | 0.541992 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 11 | 118 | 16.796875 | 85 | 20 | 35.89844 | null | 4.099609 | 0.599976 | 1.399902 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,223 | 53.46997 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 26 | 49,510 | 32,146.2031 | 24,283.3125 | 33 | white | 39.59375 | 82 | 0.28595 | 0.176971 | 23 | 0 | 0 | no | 0 | 0 | dnr after sadm | 2 | 64 | 22.199219 | 158 | 37 | 37.79688 | 101.25 | 2.699707 | 8.398438 | 1.5 | 132 | 7.369141 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,224 | 52.80798 | 1 | male | 0 | 20 | 27 | Coma | Coma | 5 | null | null | 61 | 50,898 | 34,947.625 | 30,141.4375 | 36.666657 | white | 26.597656 | 35 | 0.35199 | 0.278992 | 10 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 13 | 66 | 14.898438 | 166 | 10 | 39.59375 | 151.40625 | 3.199707 | 1.599854 | 1.099854 | 135 | 7.609375 | null | null | null | null | null | <2 mo. follow-up | 3.814941 |
8,225 | 69.22095 | 1 | male | 0 | 11 | 1,160 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 41 | 20,614 | 13,453.0234 | 12,593.8047 | 23 | white | 23.699219 | 30 | 0.530884 | 0.415955 | 5 | 0 | 0 | yes | 0.95 | 0.8 | no dnr | 11 | 77 | null | 72 | 40 | 36.19531 | 160 | 3.099609 | 1.199951 | 0.699951 | 134 | 7.439453 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
8,226 | 71.88794 | 0 | male | 0 | 9 | 1,531 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | null | 0 | 5,793 | 3,965.2519 | 3,502.97852 | 6.5 | white | 22.699219 | 35 | 0.805908 | 0.68689 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 9 | 63 | 7.699219 | 46 | 32 | 36 | 342.8125 | null | null | 1.699951 | 139 | 7.40918 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,227 | 77.35199 | 1 | male | 0 | 7 | 388 | CHF | COPD/CHF/Cirrhosis | 6 | 15 | $25-$50k | 0 | 3,522 | 2,367.6758 | 1,914.67969 | 18 | white | 16.796875 | 23 | 0.825928 | 0.715942 | 1 | 1 | 0 | yes | null | null | no dnr | 7 | 113 | 7.899414 | 76 | 24 | 36.09375 | 356 | 3.199707 | 0.599976 | 1.299805 | 140 | 7.469727 | null | null | null | 1 | 2 | no(M2 and SIP pres) | 2 |
8,228 | 60.56897 | 0 | female | 0 | 80 | 1,531 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 9 | 123,165 | 83,129.6875 | 75,931.75 | 10.75 | white | 31.796875 | 60 | 0.559937 | 0.447998 | 15 | 0 | 0 | no | null | null | no dnr | 80 | 63 | 26.097656 | 122 | 28 | 38.29688 | 150 | null | null | 6 | 143 | 7.379883 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
8,229 | 71.45795 | 0 | female | 0 | 13 | 1,530 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 7,726 | 5,278.8398 | 4,269.61719 | 11.5 | white | 20.097656 | 26 | 0.80188 | 0.680908 | 1 | 0 | 0 | yes | 0.75 | 0.65 | no dnr | 13 | 68 | 9.199219 | 102 | 24 | 35.5 | 452.375 | 3.699707 | 1.199951 | 1.399902 | 134 | 7.549805 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,230 | 78.20398 | 1 | female | 0 | 36 | 412 | Coma | Coma | 2 | 12 | null | 44 | 91,560 | 62,189.1875 | 56,398.2812 | 25.75 | white | 20.699219 | 41 | 0.362 | 0.28894 | 8 | 1 | 0 | no | 0.7 | 0.7 | no dnr | 36 | 117 | 14.199219 | 70 | 55 | 39.09375 | 255 | null | null | 1.5 | 141 | 7.459961 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,231 | 63.32098 | 1 | female | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 32,987 | 21,631.4844 | 20,892.9375 | 44 | white | 39.898438 | 59 | 0.167999 | 0.084991 | 15 | 0 | 0 | yes | null | null | dnr after sadm | 3 | 77 | 0.199982 | 132 | 28 | 36.39844 | 104.07812 | null | null | 1.5 | 136 | 7.289062 | null | null | null | null | null | <2 mo. follow-up | 2.152344 |
8,232 | 68.11798 | 1 | male | 0 | 18 | 20 | CHF | COPD/CHF/Cirrhosis | 7 | 8 | under $11k | 9 | 18,851 | 12,522.1797 | 10,364.0391 | 15.666664 | white | 33 | 67 | 0.53894 | 0.339966 | 4 | 1 | 0 | no | null | null | dnr after sadm | 3 | 56 | null | 68 | 32 | 34.79688 | 112.5 | 3.899902 | 0.899902 | 1.599854 | 128 | 7.529297 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
8,233 | 64.99695 | 1 | male | 0 | 12 | 86 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 13 | under $11k | 0 | 9,728 | 6,943.918 | 6,049.35938 | 14.5 | white | 18.097656 | 35 | 0.791992 | 0.665894 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 12 | 106 | 18.699219 | 80 | 32 | 36.59375 | 308.6875 | 2.599609 | 0.699951 | 1.5 | 142 | 7.449219 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,234 | 71.99695 | 1 | male | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 62,426 | 43,641 | 35,937.8125 | 53 | white | 34.59375 | 55 | 0.19397 | 0.102997 | 40 | 0 | 0 | metastatic | null | null | no dnr | 7 | 50 | 10.699219 | 132 | 34 | 37.89844 | 108.15625 | 3.399902 | 0.599976 | 1.199951 | 137 | 7.179688 | null | null | null | null | null | <2 mo. follow-up | 2.531738 |
8,235 | 42.77298 | 0 | male | 0 | 8 | 1,528 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 8,097 | 4,892.0781 | 4,218.04688 | 10.5 | white | 22.699219 | 24 | 0.881958 | 0.840942 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 8 | 81 | 14.898438 | 76 | 36 | 38.09375 | 135 | 4 | 0.5 | 0.899902 | 134 | 7.5 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,236 | 76.53894 | 1 | male | 0 | 4 | 824 | Colon Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 5,133 | 3,023.4414 | 3,598.87891 | 7 | white | 11 | 21 | 0.86792 | 0.704956 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 4 | 111 | 11.699219 | 53 | 20 | 36.69531 | null | 4.199219 | 0.599976 | 1.5 | 142 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,237 | 67.32397 | 1 | female | 0 | 15 | 19 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 30,640 | 20,329.25 | 18,136.3906 | 10.666664 | white | 30.398438 | 39 | 0.393982 | 0.196991 | 14 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 14 | 63 | 13 | 76 | 22 | 36.69531 | null | null | null | 4.399414 | 121 | null | null | null | null | 2 | 0 | <2 mo. follow-up | 0 |
8,238 | 53.00998 | 1 | male | 0 | 8 | 249 | Lung Cancer | Cancer | 2 | 10 | null | 0 | 9,445 | 5,743.1953 | 5,586.60938 | 8.5 | white | 18.296875 | 35 | 0.710938 | 0.428955 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 8 | 67 | 0.199982 | 66 | 24 | 38.69531 | null | 3.399902 | 1.199951 | 1.199951 | 129 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.136719 |
8,239 | 72.51996 | 1 | male | 0 | 13 | 1,040 | COPD | COPD/CHF/Cirrhosis | 5 | 8 | under $11k | 0 | 12,209 | 8,282.5 | 6,967.95703 | 17 | white | 19.597656 | 57 | 0.832886 | 0.726929 | 1 | 1 | 0 | no | null | null | no dnr | 13 | 61 | 9.099609 | 75 | 36 | 36.5 | 186.9375 | 4.099609 | 0.399963 | 2.199707 | 148 | 7.369141 | null | null | null | 3 | 1 | no(M2 and SIP pres) | 1 |
8,240 | 61.19598 | 1 | male | 0 | 150 | 1,021 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 0 | 304,423 | 202,078.875 | 207,309 | 35.25 | white | 44.5 | 64 | 0.241974 | 0.139984 | 12 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 150 | 42 | 13.898438 | 144 | 28 | 38.69531 | 92 | 2.899902 | 1.399902 | 1.5 | 133 | 7.699219 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,241 | 67.64697 | 0 | male | 0 | 42 | 1,519 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | null | 0 | 87,706 | 55,599.4062 | 53,503.0625 | 29.5 | white | 33.398438 | 49 | 0.593994 | 0.484985 | 2 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 42 | 48 | 8.199219 | 122 | 30 | 38.79688 | 114.28125 | null | null | 1.099854 | 135 | 7.389648 | null | null | null | null | 0 | null | 0 |
8,242 | 69.69495 | 0 | male | 0 | 9 | 1,520 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 9 | 7,717 | 5,093.1133 | 4,697.60938 | 13 | white | 10.199219 | 16 | 0.915894 | 0.85791 | 1 | 0 | 0 | no | 0.9 | 0.5 | dnr after sadm | 1 | 103 | 6.299805 | 70 | 24 | 37 | 266.625 | 4.099609 | 0.899902 | 1 | 144 | 7.369141 | null | null | null | null | 0 | null | 0 |
8,243 | 83.95599 | 1 | male | 0 | 13 | 122 | CHF | COPD/CHF/Cirrhosis | 5 | 7 | $11-$25k | 0 | 8,863 | 5,815.418 | 5,512.26953 | 14.5 | white | 24.898438 | 48 | 0.714966 | 0.556885 | 1 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 13 | 108 | 10.298828 | 140 | 40 | 36.69531 | 304 | null | null | 1.599854 | 137 | 7.449219 | null | null | null | 0 | 0 | null | 0 |
8,244 | 74.33496 | 1 | male | 0 | 17 | 185 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 8 | $11-$25k | 0 | 25,606 | 16,679.2188 | 13,997.1875 | 20.666656 | white | 32.195313 | 65 | 0.564941 | 0.452942 | 3 | 0 | 0 | no | null | null | no dnr | 17 | 60 | 12.398438 | 70 | 32 | 36.19531 | 163.3125 | 2.899902 | 4.299805 | 4 | 141 | 7.539062 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,245 | 59.32898 | 1 | male | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 2 | 11 | $25-$50k | 0 | 25,116 | 16,730.25 | 15,839.3594 | 41 | white | 35.898438 | 71 | 0.305969 | 0.19397 | 8 | 0 | 0 | yes | 0.05 | 0.000125 | dnr after sadm | 6 | 77 | 0.099991 | 150 | 30 | 39.19531 | 210.1875 | 2.399902 | 1.399902 | 2.399902 | 142 | 7.479492 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,246 | 67.86896 | 0 | female | 0 | 18 | 1,517 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 24,268 | 17,109 | 16,699.4375 | 27 | white | 30.296875 | 56 | 0.694946 | 0.529907 | 1 | 0 | 0 | no | 0.5 | 0.45 | no dnr | 18 | 103 | 6.199219 | 132 | 76 | 36.19531 | null | 3.399902 | 0.799927 | 2.599609 | 141 | null | null | null | null | 3 | 2 | no(M2 and SIP pres) | 2 |
8,247 | 84.95599 | 1 | female | 0 | 26 | 235 | Colon Cancer | Cancer | 1 | null | null | 0 | 28,041 | 17,552.5156 | 18,137.8594 | 16.5 | white | 17.898438 | 28 | 0.762939 | 0.510986 | 1 | 0 | 0 | metastatic | 0.5 | 0.125 | no dnr | 26 | 66 | 25.699219 | 63 | 22 | 36.5 | null | null | 1.099854 | 1 | 137 | null | null | null | null | null | null | null | 2.9375 |
8,248 | 77.95496 | 1 | male | 0 | 12 | 851 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 19,490 | 12,830.0469 | 12,229.8984 | 14 | white | 22 | 39 | 0.791992 | 0.723999 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 1 | 114 | 9.898438 | 78 | 20 | 36.39844 | 260 | 4.399414 | 0.599976 | 3.199707 | 146 | 7.40918 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,249 | 54.086 | 1 | female | 1 | 36 | 36 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 55 | 90,082 | 59,675.3438 | 63,244.0312 | 32.75 | white | 33.898438 | 34 | 0.362 | 0.244995 | 4 | 0 | 0 | no | null | null | dnr after sadm | 17 | 62 | 4.599609 | 110 | 12 | 39.79688 | 93.75 | 2.799805 | 0.799927 | 0.699951 | 151 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 2.555664 |
8,250 | 76.55597 | 1 | male | 1 | 15 | 15 | Colon Cancer | Cancer | 3 | 8 | $11-$25k | 0 | 9,715 | 6,996.0273 | 7,081.45703 | 7.333332 | white | 20.097656 | 22 | 0.744995 | 0.481995 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 1 | 137 | 9.398438 | 81 | 20 | 35.89844 | 347.5625 | 3.199707 | 1 | 0.899902 | 134 | 7.469727 | null | null | null | 1 | 1 | <2 mo. follow-up | 1 |
8,251 | 37.63397 | 0 | male | 0 | 7 | 1,510 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | >$50k | 0 | 5,411 | 3,474.9941 | 2,746.17969 | 19 | white | 20.296875 | 21 | 0.919922 | 0.86499 | 1 | 0 | 0 | no | 0.5 | 0.7 | no dnr | 7 | 71 | null | 150 | 24 | 36.19531 | null | null | null | 1 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,252 | 79.57599 | 1 | female | 0 | 6 | 48 | Lung Cancer | Cancer | 1 | 7 | under $11k | 0 | 3,169 | 2,122.8106 | 2,010.43945 | 12 | white | 21 | 19 | 0.576904 | 0.255981 | 1 | 0 | 0 | metastatic | 0.3 | 0.1 | dnr after sadm | 1 | 69 | 8.699219 | 106 | 24 | 36.5 | null | 3.199707 | 0.299988 | 0.799927 | 136 | null | null | null | null | null | null | <2 mo. follow-up | 2.426758 |
8,253 | 84.51495 | 1 | male | 0 | 7 | 14 | Coma | Coma | 7 | 8 | under $11k | 61 | 7,884 | null | null | 10.5 | white | 25.796875 | 39 | 0.098999 | 0.058998 | 1 | 1 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 1 | 116 | 17.199219 | 114 | 34 | 38.79688 | 192.5 | 4 | 0.399963 | 1.899902 | 135 | 7.399414 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
8,254 | 86.58698 | 1 | female | 0 | 8 | 235 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 5,752 | 3,898.1152 | 3,460.0293 | 10.5 | white | 17.796875 | 31 | 0.81897 | 0.705933 | 1 | 0 | 0 | no | 0.5 | 0.1 | no dnr | 8 | 79 | 6.799805 | 64 | 20 | 35.79688 | 295.1875 | null | null | 0.899902 | 134 | 7.459961 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,255 | 89.06494 | 1 | female | 0 | 4 | 319 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 1,830 | 1,201.4512 | 1,016.43994 | 14 | white | 19.296875 | 28 | 0.787964 | 0.659912 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 4 | 77 | 12.599609 | 63 | 28 | 35.89844 | 468 | null | null | 1 | 140 | 7.299805 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
8,256 | 59.18997 | 1 | male | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 2 | 6 | $25-$50k | 94 | 33,846 | 21,978.1562 | 24,646.2188 | 33 | white | 25.296875 | 45 | 0.123993 | 0.054993 | 18 | 1 | 0 | yes | null | null | no dnr | 5 | 72 | 12.5 | 113 | 32 | 38.69531 | 195.90625 | 2.399902 | 0.199982 | 1.799805 | 149 | 7.339844 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
8,257 | 60.87598 | 0 | male | 0 | 8 | 1,504 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 6,616 | 4,464.9961 | 4,013.96875 | 7.5 | white | 22.5 | 35 | 0.838989 | 0.783936 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 8 | 119 | 7.199219 | 125 | 22 | 36.39844 | 300 | 4.299805 | 0.5 | 1.899902 | 139 | 7.40918 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,258 | 71.81396 | 1 | male | 1 | 7 | 7 | Lung Cancer | Cancer | 2 | 13 | $25-$50k | 0 | 3,552 | 2,271.9121 | 2,224.57812 | 12 | white | 22.597656 | 34 | 0.560913 | 0.238983 | 1 | 0 | 0 | metastatic | null | null | no dnr | 7 | 111 | 7.799805 | 130 | 36 | 36.29688 | null | 3.699707 | 0.799927 | 1.099854 | 130 | null | null | null | null | null | null | <2 mo. follow-up | 2.407715 |
8,259 | 67.37897 | 1 | male | 1 | 24 | 24 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 34,907 | 23,411.4688 | 22,419.8281 | 20 | white | 22.199219 | 27 | 0.78894 | 0.661987 | 6 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 24 | 60 | null | 106 | 26 | 37.69531 | 155 | null | null | 1.299805 | 140 | 7.349609 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
8,260 | 61.50897 | 1 | male | 0 | 9 | 998 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | $11-$25k | 0 | 7,431 | 5,242.8906 | 4,630 | 10 | white | 10.599609 | 24 | 0.937988 | 0.893921 | 1 | 0 | 0 | no | null | null | dnr after sadm | 5 | 61 | 10.298828 | 79 | 20 | 36.09375 | null | 4.5 | 0.799927 | 1.299805 | 135 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
8,261 | 68.78595 | 1 | male | 0 | 4 | 185 | Lung Cancer | Cancer | 4 | 8 | under $11k | 9 | 4,051 | 2,365.6758 | 1,519.08984 | 11 | white | 18 | 41 | 0.641968 | 0.333984 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 1 | 113 | 7.5 | 98 | 28 | 35.29688 | null | 4.099609 | 0.599976 | 2.099609 | 134 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.737793 |
8,262 | 49.89499 | 0 | female | 0 | 7 | 1,495 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | under $11k | 0 | 7,770 | 5,283.8047 | 6,033.08984 | 32 | white | 23.398438 | 34 | 0.858887 | 0.809937 | 1 | 1 | 0 | no | 1 | 1 | no dnr | 7 | 120 | 21.898438 | 133 | 22 | 38 | null | 2.799805 | 0.599976 | 1.799805 | 147 | null | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
8,263 | 69.40198 | 1 | female | 0 | 12 | 1,133 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 25,649 | 17,458.9375 | 14,941.2891 | 18.5 | white | 30.199219 | 40 | 0.605957 | 0.5 | 8 | 1 | 0 | no | 0.75 | 0.6 | no dnr | 12 | 71 | 24 | 96 | 24 | 37.69531 | 118.35938 | null | null | 4.399414 | 137 | 7.379883 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,264 | 73.17499 | 1 | male | 1 | 22 | 22 | MOSF w/Malig | ARF/MOSF | 1 | 12 | under $11k | 0 | 42,914 | 28,734.4531 | 30,136.5156 | 40.333313 | white | 27.796875 | 54 | 0.534912 | 0.419983 | 5 | 0 | 0 | yes | 0.9 | 0.9 | dnr after sadm | 13 | 57 | 9.798828 | 160 | 14 | 38.29688 | 203.3125 | 2.599609 | 6.099609 | 1 | 133 | 7.469727 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
8,265 | 85.41296 | 1 | male | 0 | 8 | 1,012 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | under $11k | 0 | 13,014 | 8,535.0312 | 8,705.04688 | 16 | white | 30.199219 | 54 | 0.439941 | 0.319946 | 5 | 0 | 0 | yes | null | null | dnr after sadm | 3 | 69 | 15.5 | 112 | 28 | 36.69531 | 125.70312 | null | null | 1.699951 | 143 | 7.55957 | null | null | null | null | null | null | 3.962891 |
8,266 | 66.71899 | 1 | female | 0 | 5 | 372 | Lung Cancer | Cancer | 2 | null | null | 0 | 3,790 | 2,324.3262 | 2,037.11914 | 8 | white | 12.398438 | 18 | 0.785889 | 0.550903 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 5 | 106 | 6.199219 | 114 | 24 | 37.5 | null | 3.899902 | 0.299988 | 0.899902 | 138 | null | null | null | null | null | null | null | 2.019531 |
8,267 | 69.44299 | 1 | female | 0 | 11 | 405 | COPD | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 8,271 | 5,386.6602 | 8,312.35938 | 14.5 | other | 17.699219 | 32 | 0.795898 | 0.671997 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 11 | 104 | 10 | 83 | 40 | 37.59375 | 280.9375 | 3.399902 | 0.099991 | 0.799927 | 133 | 7.359375 | null | null | null | null | null | null | 4.601563 |
8,268 | 70.64795 | 1 | female | 0 | 14 | 15 | Coma | Coma | 0 | 12 | $25-$50k | 100 | 12,994 | 8,343.4141 | 8,123.11719 | 20.333328 | white | 24 | 44 | 0.156982 | 0.103989 | 1 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 1 | 121 | 28.5 | 138 | 40 | 38.19531 | 220.40625 | 4.5 | 0.699951 | 1.299805 | 138 | 7.539062 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,269 | 64.35596 | 0 | male | 0 | 7 | 1,489 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 9,355 | 5,870.8125 | 5,610.50781 | 12 | white | 19.199219 | 21 | 0.866943 | 0.819946 | 1 | 0 | 0 | no | 0.99 | 0.9 | no dnr | 7 | 103 | 9.898438 | 58 | 24 | 36.59375 | 325.875 | 4.099609 | 0.599976 | 1.5 | 133 | 7.429688 | null | null | null | null | null | null | 2.389648 |
8,270 | 56.54498 | 1 | male | 0 | 3 | 664 | Lung Cancer | Cancer | 1 | null | null | 0 | 2,563 | 1,645.4492 | 1,407.18945 | 13 | white | 20.398438 | 15 | 0.656982 | 0.352966 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 3 | 104 | null | 79 | 20 | 36 | null | null | 0.399963 | 1 | 125 | null | null | null | null | null | null | null | 2.131348 |
8,271 | 68.68994 | 0 | male | 0 | 5 | 1,484 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 9,280 | 5,733.3477 | 6,112.65625 | 19 | white | 20.5 | 32 | 0.840942 | 0.786987 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 5 | 77 | 16.398438 | 79 | 25 | 36.19531 | 242.84375 | 4 | 0.599976 | 1.699951 | 137 | 7.419922 | null | null | null | null | null | null | 1.833496 |
8,272 | 57.30899 | 1 | male | 0 | 19 | 20 | MOSF w/Malig | ARF/MOSF | 0 | 12 | under $11k | 0 | 59,005 | 38,558.0625 | 46,547 | 32.666657 | white | 21.296875 | 41 | 0.728882 | 0.644897 | 3 | 0 | 0 | yes | 0.05 | 0.000125 | dnr after sadm | 15 | 52 | 9.699219 | 76 | 32 | 39.09375 | 196.65625 | 2.599609 | 0.399963 | 1.199951 | 138 | 7.459961 | null | null | null | 2 | 0 | <2 mo. follow-up | 0 |
8,273 | 73.78796 | 1 | female | 0 | 114 | 540 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 116,672 | 82,243.5625 | 78,932.1875 | 19 | white | 35.5 | 43 | 0.444946 | 0.324951 | 6 | 0 | 1 | no | null | null | dnr after sadm | 39 | 44 | 16.398438 | 102 | 28 | 38.89844 | 150 | null | null | 1.5 | 137 | 7.459961 | null | null | null | null | 5 | no(M2 and SIP pres) | 5 |
8,274 | 54.28299 | 0 | female | 0 | 12 | 1,483 | CHF | COPD/CHF/Cirrhosis | 4 | 11 | under $11k | 0 | 15,432 | 10,693.2188 | 10,255.8594 | 30 | white | 14.199219 | 17 | 0.929932 | 0.879883 | 1 | 1 | 0 | no | null | null | no dnr | 12 | 68 | 8.599609 | 65 | 22 | 38.29688 | null | 3.299805 | 1 | 1.199951 | 139 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
8,275 | 72.849 | 0 | female | 0 | 9 | 1,480 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | under $11k | 0 | 5,383 | 3,525.8086 | 4,021.81836 | 7 | white | 9.199219 | 35 | 0.92395 | 0.870972 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 67 | 18.5 | 70 | 24 | 37.69531 | 239.125 | 4.599609 | 0.299988 | 1.5 | 137 | 7.369141 | null | null | null | null | null | no(M2 and SIP pres) | 2.691406 |
8,276 | 71.81897 | 1 | female | 0 | 6 | 879 | Lung Cancer | Cancer | 3 | 16 | under $11k | 0 | 4,949 | 3,180.9316 | 3,546.20898 | 7 | white | 11.798828 | 24 | 0.785889 | 0.550903 | 1 | 0 | 0 | metastatic | 0.9 | 0.9 | no dnr | 6 | 78 | 9.298828 | 85 | 20 | 36.39844 | null | 3.799805 | 0.399963 | 1.199951 | 134 | null | null | null | null | null | null | null | 2.199219 |
8,277 | 76.46497 | 1 | female | 0 | 13 | 17 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 16 | under $11k | 0 | 16,170 | 11,200.375 | 11,975.1328 | 11.5 | white | 21.097656 | 31 | 0.656982 | 0.47998 | 1 | 1 | 0 | no | 1 | 1 | dnr after sadm | 10 | 85 | 7.099609 | 92 | 20 | 36.39844 | 338.0625 | 2.799805 | 2.799805 | 1.699951 | 132 | 7.489258 | null | null | null | 1 | null | <2 mo. follow-up | 1.1669 |
8,278 | 53.72998 | 1 | male | 0 | 26 | 28 | Coma | Coma | 4 | 11 | >$50k | 94 | 47,203 | 31,308.5312 | 35,985.875 | 28.25 | white | 26.699219 | 38 | 0.269958 | 0.201996 | 1 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 15 | 57 | 34.59375 | 108 | 12 | 39.19531 | 180 | 4.5 | 0.5 | 1.299805 | 133 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,279 | 59.44998 | 1 | female | 0 | 7 | 439 | Colon Cancer | Cancer | 1 | 12 | >$50k | 0 | 7,654 | 4,569.625 | 5,112.92969 | 9 | white | 14.398438 | 12 | 0.85791 | 0.682983 | 1 | 0 | 0 | metastatic | 0.6 | 0.4 | no dnr | 7 | 75 | null | 65 | 20 | 36.69531 | null | null | null | null | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,280 | 92.53894 | 1 | male | 0 | 9 | 234 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | null | 0 | 5,446 | 3,765.416 | 4,130.79688 | 4 | hispanic | 19.398438 | 37 | 0.770996 | 0.635986 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 78 | 7.399414 | 70 | 20 | 36.39844 | 252.375 | null | null | 2.399902 | 140 | 7.439453 | null | null | null | null | 5 | no(M2 and SIP pres) | 5 |
8,281 | 59.556 | 1 | male | 0 | 5 | 389 | Lung Cancer | Cancer | 1 | 8 | under $11k | 0 | 4,463 | 2,632.8672 | 1,954.90918 | 11 | white | 14.898438 | 22 | 0.758911 | 0.504883 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 5 | 77 | 5.099609 | 74 | 24 | 36.29688 | null | null | 0.299988 | 1.399902 | 137 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.958984 |
8,282 | 42.965 | 1 | male | 1 | 28 | 28 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 125,903 | 78,030.25 | 85,739.0625 | 42 | white | 40 | 55 | 0.514893 | 0.398987 | 8 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 28 | 43 | 19.5 | 138 | 36 | 38.79688 | 235 | null | null | 3 | 144 | 7.529297 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
8,283 | 63.25 | 0 | female | 0 | 22 | 1,469 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 37 | 30,327 | 21,310.875 | 20,660.6875 | 24.333328 | white | 40.09375 | 74 | 0.245972 | 0.142975 | 2 | 1 | 0 | no | null | null | no dnr | 22 | 43 | 23.5 | 146 | 40 | 38.39844 | 203.3125 | null | null | 2.199707 | 134 | 7.25 | null | null | null | null | 0 | null | 0 |
8,284 | 78.04797 | 1 | male | 0 | 8 | 10 | MOSF w/Malig | ARF/MOSF | 1 | 8 | under $11k | 26 | 21,947 | 14,963.3359 | 15,439.25 | 24.5 | other | 23.5 | 34 | 0.501953 | 0.384949 | 7 | 0 | 0 | yes | null | null | dnr after sadm | 5 | 68 | 4.699219 | 66 | 12 | 36.29688 | 250 | null | 0.699951 | 7.099609 | 140 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,285 | 80.08997 | 1 | female | 0 | 7 | 1,373 | COPD | COPD/CHF/Cirrhosis | 3 | 15 | $11-$25k | 0 | 3,531 | 2,403.7617 | 2,434.28906 | 7 | white | 10.599609 | 33 | 0.891968 | 0.81897 | 1 | 0 | 0 | no | 0.95 | 0.95 | dnr after sadm | 1 | 71 | 10.798828 | 87 | 16 | 36 | 223.78125 | 4.899414 | 0.799927 | 0.799927 | 139 | 7.419922 | null | null | null | null | null | no(M2 and SIP pres) | 2.409668 |
8,286 | 61.60999 | 1 | male | 1 | 6 | 6 | Coma | Coma | 1 | 14 | $11-$25k | 100 | 3,837 | 2,556.6562 | 2,668.53906 | 19 | white | 18.796875 | 27 | 0.390991 | 0.316956 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 111 | 14.199219 | 101 | 28 | 38.59375 | 422.5 | 4.599609 | 0.5 | 1.399902 | 142 | 7.30957 | null | null | null | null | null | <2 mo. follow-up | 2.325684 |
8,287 | 72.59998 | 1 | male | 0 | 11 | 739 | COPD | COPD/CHF/Cirrhosis | 3 | 10 | under $11k | 0 | 7,230 | 4,681.4297 | 4,973.36719 | 7.5 | white | 19 | 31 | 0.839966 | 0.736938 | 1 | 0 | 0 | no | 0.75 | 0.5 | dnr before sadm | -1 | 67 | 14 | 104 | 32 | 36.09375 | 232 | 3.799805 | 0.699951 | 1.199951 | 141 | 7.379883 | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
8,288 | 90.26697 | 1 | female | 0 | 16 | 20 | Coma | Coma | 4 | 8 | under $11k | 44 | 8,338 | 5,678.207 | 4,818.97656 | 5.666664 | white | 23 | 43 | 0.262939 | 0.195984 | 1 | 1 | 1 | no | null | null | no dnr | 16 | 113 | 27.398438 | 107 | 24 | 38.59375 | null | 3.599609 | 0.699951 | 2 | 134 | null | null | null | null | null | null | <2 mo. follow-up | 5.351563 |
8,289 | 63.18698 | 1 | male | 0 | 7 | 345 | Lung Cancer | Cancer | 2 | 8 | under $11k | 0 | 3,640 | 2,633.0938 | 2,440.39844 | 9 | white | 8 | 9 | 0.848999 | 0.666992 | 1 | 0 | 0 | metastatic | 0.3 | 0.1 | dnr after sadm | 2 | 83 | null | 101 | 24 | 36.5 | null | 4.199219 | 0.399963 | 1 | 140 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
8,290 | 50.71298 | 1 | male | 1 | 5 | 5 | Coma | Coma | 0 | 10 | null | 0 | 14,165 | 9,191.4375 | 9,033.46875 | 29 | white | 18.597656 | 7 | 0.850952 | 0.820923 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 117 | 18.796875 | 72 | 24 | 38.59375 | 163.25 | null | null | 0.899902 | 138 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 1.468506 |
8,291 | 63.33499 | 1 | male | 0 | 12 | 1,138 | CHF | COPD/CHF/Cirrhosis | 3 | 16 | null | 0 | 10,998 | 7,141.5117 | 6,555.09766 | 14.5 | white | 22.199219 | 36 | 0.841919 | 0.741943 | 1 | 0 | 0 | no | null | null | no dnr | 12 | 59 | 10.5 | 39 | 20 | 36.39844 | null | null | null | 1.5 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,292 | 76.34796 | 1 | male | 0 | 6 | 198 | Lung Cancer | Cancer | 2 | 10 | under $11k | 0 | 4,317 | 2,808.6426 | 2,515.12891 | 11 | white | 19.597656 | 22 | 0.620972 | 0.306946 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | no dnr | 6 | 103 | 5.799805 | 122 | 20 | 36.79688 | null | 3.399902 | 0.099991 | 0.799927 | 138 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.441895 |
8,293 | 78.24799 | 0 | female | 0 | 13 | 1,456 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 8,286 | 5,489.4648 | 5,500.75781 | 5 | white | 22.097656 | 27 | 0.761963 | 0.621948 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 13 | 107 | 6.099609 | 71 | 28 | 36.29688 | 271.375 | 3.399902 | 0.299988 | 0.599976 | 128 | 7.379883 | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
8,294 | 62.185 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 20 | >$50k | 37 | 104,716 | 71,111 | 72,206.6875 | 38 | white | 42.898438 | 77 | 0.095993 | 0.038994 | 42 | 0 | 0 | no | 0.2 | 0.008 | dnr after sadm | 1 | 53 | 35.09375 | 70 | 28 | 34.39844 | 137.5 | 3.299805 | 5 | 6.299805 | 136 | 7.349609 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,295 | 78.42798 | 0 | female | 0 | 26 | 1,455 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 9 | 63,652 | 43,971.6875 | 41,493.0938 | 19.5 | white | 26.898438 | 35 | 0.504883 | 0.387939 | 11 | 0 | 0 | yes | null | null | dnr after sadm | 1 | 81 | 22.5 | 128 | 26 | 38.29688 | 351.375 | null | null | 2.699707 | 137 | 7.449219 | null | null | null | null | null | null | 2.589844 |
8,296 | 42.38998 | 0 | male | 0 | 37 | 1,455 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | $11-$25k | 0 | 56,976 | 37,833.6562 | 44,572.6562 | 24.25 | white | 33.398438 | 72 | 0.743896 | 0.66394 | 1 | 1 | 0 | no | 0.2 | 0.2 | no dnr | 37 | 54 | 11.5 | 160 | 50 | 40 | 188.5625 | 2.099609 | 0.599976 | 0.899902 | 150 | 7.389648 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
8,297 | 53.34698 | 1 | male | 0 | 5 | 160 | Lung Cancer | Cancer | 3 | 12 | $25-$50k | 0 | 3,856 | 2,521.207 | 2,108.17969 | 8 | white | 23.796875 | 18 | 0.585938 | 0.265991 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | no dnr | 5 | 109 | 12.599609 | 122 | 20 | 36.19531 | null | null | 0.299988 | 0.699951 | 132 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
8,298 | 58.90997 | 1 | female | 0 | 9 | 55 | COPD | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 0 | 7,424 | 4,781.4648 | 5,585.58984 | 9 | white | 15.898438 | 32 | 0.918945 | 0.863892 | 1 | 1 | 0 | no | 0.95 | 0.95 | no dnr | 9 | 75 | 11.099609 | 66 | 24 | 36.29688 | 204.75 | 3.799805 | 0.5 | 0.899902 | 143 | 7.439453 | null | null | null | 1 | 2 | no(M2 and SIP pres) | 2 |
8,299 | 85.94696 | 1 | male | 0 | 11 | 127 | COPD | COPD/CHF/Cirrhosis | 3 | 16 | under $11k | 0 | 7,914 | 5,262.6758 | 5,151.19922 | 8.5 | white | 17.296875 | 30 | 0.784912 | 0.655884 | 1 | 1 | 1 | no | 1 | 1 | no dnr | 11 | 60 | 8.199219 | 79 | 24 | 35.89844 | null | null | 0.5 | 1.199951 | 131 | null | null | null | null | null | null | Coma or Intub | 4.84375 |
8,300 | 22.55699 | 1 | male | 0 | 5 | 6 | MOSF w/Malig | ARF/MOSF | 3 | 13 | under $11k | 0 | 17,616 | 12,264.8516 | 9,851.84375 | 41 | white | 38.195313 | 57 | 0.403992 | 0.284973 | 1 | 0 | 0 | yes | 0.01 | 0.000001 | dnr after sadm | 5 | 114 | 2.5 | 146 | 36 | 39.59375 | 304.75 | 2.799805 | 0.799927 | 2.199707 | 125 | 7.479492 | null | null | null | null | 5 | <2 mo. follow-up | 5 |